हिंदी में पढ़ें

SRL Diagnostics

Diagnostic industry may log 55% revenue growth in FY22: Report

Diagnostic industry may log 55% revenue growth in FY22: Report

Thu, Dec 16, 2021

The pandemic sharply boosted revenue and operating profit margins of national-level diagnostic firms during first half of the year which may help them log out 2021-22 with around 55 per cent jump in topline growth and around 800 basis points increase in operating margins, says a report.

Fortis withdraws "arrangement and amalgamation" scheme

Fortis withdraws "arrangement and amalgamation" scheme

Fri, Jun 15, 2018

The company cited delays in the process as one of the reasons to withdraw the scheme. FHL said the entire process was expected to be completed in 6-8 months, however, due to reasons beyond its control, the process has taken over 19 months and is still not complete.

Fortis scraps SRL, Fortis Malar merger scheme

Fortis scraps SRL, Fortis Malar merger scheme

Thu, Jun 14, 2018

"The entire process was expected to take 6-8 months, however, due to reasons beyond the company's control, the process has taken over 19 months and is still not complete," Fortis Healthcare said in a late night filing on Wednesday.

TRENDING NOW

Subscribe to Thyrocare Technologies IPO for long-term: Experts

Subscribe to Thyrocare Technologies IPO for long-term: Experts

Tue, Apr 26, 2016

Diagnostics company Thyrocare Technologies is set to enter the capital market on Wednesday to raise nearly Rs 480 crore. Experts see the company's valuation fairly attractive and recommends investors to subscribe to the issue for long-term.

Load More

LIVE TV

By accepting cookies, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.

x